ID   TPM1_RAT                Reviewed;         284 AA.
AC   P04692; P06469; P18342; P18343; P18344; P19354; Q53X09; Q63582; Q63608;
AC   Q63609;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   04-APR-2006, sequence version 3.
DT   29-MAY-2024, entry version 190.
DE   RecName: Full=Tropomyosin alpha-1 chain;
DE   AltName: Full=Alpha-tropomyosin;
DE   AltName: Full=Tropomyosin-1;
GN   Name=Tpm1; Synonyms=Alpha-tm, Tpma;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=3838802; DOI=10.1038/315067a0;
RA   Ruiz-Opazo N., Weinberger J., Nadal-Ginard B.;
RT   "Comparison of alpha-tropomyosin sequences from smooth and striated
RT   muscle.";
RL   Nature 315:67-70(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND ALTERNATIVE SPLICING.
RX   PubMed=3558368; DOI=10.1016/s0021-9258(18)61260-8;
RA   Ruiz-Opazo N., Nadal-Ginard B.;
RT   "Alpha-tropomyosin gene organization. Alternative splicing of duplicated
RT   isotype-specific exons accounts for the production of smooth and striated
RT   muscle isoforms.";
RL   J. Biol. Chem. 262:4755-4765(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND ALTERNATIVE SPLICING.
RX   PubMed=3352602; DOI=10.1128/mcb.8.2.679-694.1988;
RA   Wieczorek D.F., Smith C.W., Nadal-Ginard B.;
RT   "The rat alpha-tropomyosin gene generates a minimum of six different mRNAs
RT   coding for striated, smooth, and nonmuscle isoforms by alternative
RT   splicing.";
RL   Mol. Cell. Biol. 8:679-694(1988).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 3; 4 AND 5).
RC   TISSUE=Brain;
RX   PubMed=2320008; DOI=10.1128/mcb.10.4.1729-1742.1990;
RA   Lees-Miller J.P., Goodwin L.O., Helfman D.M.;
RT   "Three novel brain tropomyosin isoforms are expressed from the rat alpha-
RT   tropomyosin gene through the use of alternative promoters and alternative
RT   RNA processing.";
RL   Mol. Cell. Biol. 10:1729-1742(1990).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 6; 7 AND 8).
RX   PubMed=2022655; DOI=10.1016/s0021-9258(18)92990-x;
RA   Goodwin L.O., Lees-Miller J.P., Leonard M.A., Cheley S.B., Helfman D.M.;
RT   "Four fibroblast tropomyosin isoforms are expressed from the rat alpha-
RT   tropomyosin gene via alternative RNA splicing and the use of two
RT   promoters.";
RL   J. Biol. Chem. 266:8408-8415(1991).
RN   [6]
RP   PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=6179945; DOI=10.1016/s0021-9258(18)33935-8;
RA   Garfinkel L.I., Periasamy M., Nadal-Ginard B.;
RT   "Cloning and characterization of cDNA sequences corresponding to myosin
RT   light chains 1, 2, and 3, troponin-C, troponin-T, alpha-tropomyosin, and
RT   alpha-actin.";
RL   J. Biol. Chem. 257:11078-11086(1982).
RN   [7]
RP   PROTEIN SEQUENCE OF 92-101; 141-149; 218-226 AND 251-270, PARTIAL PROTEIN
RP   SEQUENCE (ISOFORMS 4/5/7/8), AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain, Hippocampus, and Spinal cord;
RA   Lubec G., Afjehi-Sadat L., Diao W., Kang S.U., Lubec S.;
RL   Submitted (SEP-2007) to UniProtKB.
RN   [8]
RP   FUNCTION, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=7568216; DOI=10.1073/pnas.92.21.9776;
RA   Gimona M., Watakabe A., Helfman D.M.;
RT   "Specificity of dimer formation in tropomyosins: influence of alternatively
RT   spliced exons on homodimer and heterodimer assembly.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:9776-9780(1995).
RN   [9]
RP   FUNCTION, AND SUBUNIT.
RX   PubMed=22812662; DOI=10.1021/bi300340r;
RA   Kalyva A., Schmidtmann A., Geeves M.A.;
RT   "In vitro formation and characterization of the skeletal muscle alpha.beta
RT   tropomyosin heterodimers.";
RL   Biochemistry 51:6388-6399(2012).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-45; SER-174; SER-252 AND
RP   TYR-261, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Binds to actin filaments in muscle and non-muscle cells
CC       (PubMed:22812662, PubMed:7568216). Plays a central role, in association
CC       with the troponin complex, in the calcium dependent regulation of
CC       vertebrate striated muscle contraction (PubMed:22812662). Smooth muscle
CC       contraction is regulated by interaction with caldesmon. In non-muscle
CC       cells is implicated in stabilizing cytoskeleton actin filaments.
CC       {ECO:0000269|PubMed:22812662, ECO:0000269|PubMed:7568216}.
CC   -!- SUBUNIT: Homodimer (PubMed:22812662, PubMed:7568216). Heterodimer of an
CC       alpha (TPM1, TPM3 or TPM4) and a beta (TPM2) chain (PubMed:22812662,
CC       PubMed:7568216). Interacts with HRG (via the HRR domain); the
CC       interaction contributes to the antiangiogenic properties of the
CC       histidine/proline-rich region (HRR) of HRG (By similarity). Interacts
CC       (via N-terminus) with LMOD2 (via N-terminus) and TMOD1 (via N-terminus)
CC       (By similarity). {ECO:0000250|UniProtKB:P04268,
CC       ECO:0000250|UniProtKB:P09493, ECO:0000269|PubMed:22812662,
CC       ECO:0000269|PubMed:7568216}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:7568216}. Note=Associates with F-actin stress
CC       fibers (PubMed:7568216). {ECO:0000269|PubMed:7568216}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1; Synonyms=Skeletal muscle;
CC         IsoId=P04692-1; Sequence=Displayed;
CC       Name=2; Synonyms=Smooth muscle;
CC         IsoId=P04692-2; Sequence=VSP_006582, VSP_006584;
CC       Name=3; Synonyms=Brain TMBr-1;
CC         IsoId=P04692-3; Sequence=VSP_006585;
CC       Name=4; Synonyms=Brain TMBr-2;
CC         IsoId=P04692-4; Sequence=VSP_006581, VSP_006586;
CC       Name=5; Synonyms=Brain TMBr-3;
CC         IsoId=P04692-5; Sequence=VSP_006581, VSP_006585;
CC       Name=6; Synonyms=Fibroblast TM-2;
CC         IsoId=P04692-6; Sequence=VSP_006584;
CC       Name=7; Synonyms=Fibroblast 5a;
CC         IsoId=P04692-7; Sequence=VSP_006581, VSP_006584;
CC       Name=8; Synonyms=Fibroblast 5b;
CC         IsoId=P04692-8; Sequence=VSP_006581, VSP_006583, VSP_006584;
CC   -!- DOMAIN: The molecule is in a coiled coil structure that is formed by 2
CC       polypeptide chains. The sequence exhibits a prominent seven-residues
CC       periodicity.
CC   -!- PTM: Phosphorylated at Ser-283 by DAPK1 in response to oxidative stress
CC       and this phosphorylation enhances stress fiber formation in endothelial
CC       cells. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the tropomyosin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION: [Isoform 2]:
CC       Sequence=CAA26258.1; Type=Miscellaneous discrepancy; Note=miscellaneous discrepancy.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M15474; AAA21801.1; -; Genomic_DNA.
DR   EMBL; M15472; AAA21801.1; JOINED; Genomic_DNA.
DR   EMBL; M15473; AAA21801.1; JOINED; Genomic_DNA.
DR   EMBL; M16432; AAA21801.1; JOINED; Genomic_DNA.
DR   EMBL; M16433; AAA21801.1; JOINED; Genomic_DNA.
DR   EMBL; M18135; AAA21803.1; ALT_TERM; Genomic_DNA.
DR   EMBL; M16432; AAA21803.1; JOINED; Genomic_DNA.
DR   EMBL; M15472; AAA21803.1; JOINED; Genomic_DNA.
DR   EMBL; M16433; AAA21803.1; JOINED; Genomic_DNA.
DR   EMBL; M15473; AAA21803.1; JOINED; Genomic_DNA.
DR   EMBL; M18135; AAA21804.1; -; Genomic_DNA.
DR   EMBL; M16432; AAA21804.1; JOINED; Genomic_DNA.
DR   EMBL; M16433; AAA21804.1; JOINED; Genomic_DNA.
DR   EMBL; M18135; AAA21805.1; -; Genomic_DNA.
DR   EMBL; M16432; AAA21805.1; JOINED; Genomic_DNA.
DR   EMBL; M15472; AAA21805.1; JOINED; Genomic_DNA.
DR   EMBL; M16433; AAA21805.1; JOINED; Genomic_DNA.
DR   EMBL; X02411; CAA26258.1; ALT_SEQ; mRNA.
DR   EMBL; M34135; AAA42252.1; -; mRNA.
DR   EMBL; M34134; AAA42253.1; -; mRNA.
DR   EMBL; M34136; AAA42254.1; -; mRNA.
DR   EMBL; M34137; AAA40773.1; -; Genomic_DNA.
DR   EMBL; M34138; AAA40774.1; -; Genomic_DNA.
DR   EMBL; M60666; AAA42290.1; -; mRNA.
DR   EMBL; M60668; AAA18098.1; -; mRNA.
DR   EMBL; M60669; AAA18099.1; -; mRNA.
DR   EMBL; X02412; CAA26259.1; -; mRNA.
DR   PIR; A34787; A34787.
DR   PIR; A39816; A39816.
DR   PIR; B27407; B27407.
DR   PIR; B34787; B34787.
DR   PIR; C34787; C34787.
DR   PIR; C39816; C39816.
DR   PIR; D39816; D39816.
DR   RefSeq; NP_001029241.1; NM_001034069.1.
DR   RefSeq; NP_001029244.1; NM_001034072.1. [P04692-3]
DR   RefSeq; NP_001029245.1; NM_001034073.1.
DR   RefSeq; NP_001029246.1; NM_001034074.1.
DR   RefSeq; NP_001029247.1; NM_001034075.1.
DR   RefSeq; NP_001288265.1; NM_001301336.1. [P04692-1]
DR   RefSeq; NP_062004.1; NM_019131.2. [P04692-4]
DR   PDB; 1IHQ; NMR; -; A/B=206-209.
DR   PDB; 1KQL; X-ray; 2.70 A; A/B=254-284.
DR   PDB; 1MV4; NMR; -; A/B=251-284.
DR   PDB; 1TMZ; NMR; -; A/B=1-14.
DR   PDB; 2B9C; X-ray; 2.30 A; A/B=89-208.
DR   PDB; 2G9J; NMR; -; A/B=1-14, C/D=251-284.
DR   PDB; 3AZD; X-ray; 0.98 A; A/B=206-209.
DR   PDBsum; 1IHQ; -.
DR   PDBsum; 1KQL; -.
DR   PDBsum; 1MV4; -.
DR   PDBsum; 1TMZ; -.
DR   PDBsum; 2B9C; -.
DR   PDBsum; 2G9J; -.
DR   PDBsum; 3AZD; -.
DR   AlphaFoldDB; P04692; -.
DR   BMRB; P04692; -.
DR   SMR; P04692; -.
DR   BioGRID; 246968; 7.
DR   DIP; DIP-29020N; -.
DR   IntAct; P04692; 4.
DR   STRING; 10116.ENSRNOP00000074187; -.
DR   GlyGen; P04692; 6 sites, 1 O-linked glycan (6 sites).
DR   iPTMnet; P04692; -.
DR   PhosphoSitePlus; P04692; -.
DR   SwissPalm; P04692; -.
DR   jPOST; P04692; -.
DR   PaxDb; 10116-ENSRNOP00000024493; -.
DR   Ensembl; ENSRNOT00000048044.6; ENSRNOP00000048499.3; ENSRNOG00000018184.9. [P04692-1]
DR   Ensembl; ENSRNOT00055046005; ENSRNOP00055037733; ENSRNOG00055026478. [P04692-1]
DR   Ensembl; ENSRNOT00060033205; ENSRNOP00060027176; ENSRNOG00060018824. [P04692-1]
DR   Ensembl; ENSRNOT00065011561; ENSRNOP00065008418; ENSRNOG00065007328. [P04692-1]
DR   GeneID; 24851; -.
DR   KEGG; rno:24851; -.
DR   AGR; RGD:3898; -.
DR   CTD; 7168; -.
DR   RGD; 3898; Tpm1.
DR   eggNOG; KOG1003; Eukaryota.
DR   GeneTree; ENSGT01030000234542; -.
DR   HOGENOM; CLU_055027_0_0_1; -.
DR   InParanoid; P04692; -.
DR   OrthoDB; 5398117at2759; -.
DR   PhylomeDB; P04692; -.
DR   TreeFam; TF351519; -.
DR   Reactome; R-RNO-390522; Striated Muscle Contraction.
DR   Reactome; R-RNO-445355; Smooth Muscle Contraction.
DR   EvolutionaryTrace; P04692; -.
DR   PRO; PR:P04692; -.
DR   Proteomes; UP000002494; Chromosome 8.
DR   Bgee; ENSRNOG00000018184; Expressed in skeletal muscle tissue and 20 other cell types or tissues.
DR   ExpressionAtlas; P04692; baseline and differential.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:UniProtKB.
DR   GO; GO:0005884; C:actin filament; IBA:GO_Central.
DR   GO; GO:0032059; C:bleb; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0030016; C:myofibril; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0032587; C:ruffle membrane; ISO:RGD.
DR   GO; GO:0001725; C:stress fiber; ISO:RGD.
DR   GO; GO:0003779; F:actin binding; IDA:RGD.
DR   GO; GO:0051015; F:actin filament binding; IDA:UniProtKB.
DR   GO; GO:0008092; F:cytoskeletal protein binding; ISO:RGD.
DR   GO; GO:0097718; F:disordered domain specific binding; IPI:CAFA.
DR   GO; GO:0042802; F:identical protein binding; IDA:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0051693; P:actin filament capping; IDA:RGD.
DR   GO; GO:0007015; P:actin filament organization; IBA:GO_Central.
DR   GO; GO:0060048; P:cardiac muscle contraction; IDA:RGD.
DR   GO; GO:0034614; P:cellular response to reactive oxygen species; ISO:RGD.
DR   GO; GO:0001701; P:in utero embryonic development; ISO:RGD.
DR   GO; GO:0006936; P:muscle contraction; TAS:RGD.
DR   GO; GO:0030049; P:muscle filament sliding; IDA:BHF-UCL.
DR   GO; GO:0030336; P:negative regulation of cell migration; IGI:BHF-UCL.
DR   GO; GO:1904753; P:negative regulation of vascular associated smooth muscle cell migration; ISO:RGD.
DR   GO; GO:1904706; P:negative regulation of vascular associated smooth muscle cell proliferation; ISO:RGD.
DR   GO; GO:0032781; P:positive regulation of ATP-dependent activity; IDA:BHF-UCL.
DR   GO; GO:0045785; P:positive regulation of cell adhesion; IGI:BHF-UCL.
DR   GO; GO:0003065; P:positive regulation of heart rate by epinephrine; ISO:RGD.
DR   GO; GO:0051496; P:positive regulation of stress fiber assembly; IGI:BHF-UCL.
DR   GO; GO:0008360; P:regulation of cell shape; ISO:RGD.
DR   GO; GO:0031529; P:ruffle organization; IGI:BHF-UCL.
DR   GO; GO:0045214; P:sarcomere organization; ISO:RGD.
DR   GO; GO:0055010; P:ventricular cardiac muscle tissue morphogenesis; ISO:RGD.
DR   GO; GO:0042060; P:wound healing; IGI:BHF-UCL.
DR   Gene3D; 1.20.5.170; -; 2.
DR   Gene3D; 1.20.5.340; -; 1.
DR   InterPro; IPR000533; Tropomyosin.
DR   PANTHER; PTHR19269; TROPOMYOSIN; 1.
DR   PANTHER; PTHR19269:SF80; TROPOMYOSIN ALPHA-1 CHAIN; 1.
DR   Pfam; PF00261; Tropomyosin; 1.
DR   PRINTS; PR00194; TROPOMYOSIN.
DR   SUPFAM; SSF57997; Tropomyosin; 1.
DR   PROSITE; PS00326; TROPOMYOSIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Actin-binding; Alternative splicing;
KW   Coiled coil; Cytoplasm; Cytoskeleton; Direct protein sequencing;
KW   Muscle protein; Phosphoprotein; Reference proteome.
FT   CHAIN           1..284
FT                   /note="Tropomyosin alpha-1 chain"
FT                   /id="PRO_0000205624"
FT   REGION          1..38
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          116..136
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          1..284
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:P09493"
FT   MOD_RES         45
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         174
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         186
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P58771"
FT   MOD_RES         206
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P58771"
FT   MOD_RES         252
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         261
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         271
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P58771"
FT   MOD_RES         283
FT                   /note="Phosphoserine; by DAPK1"
FT                   /evidence="ECO:0000250|UniProtKB:P09493"
FT   VAR_SEQ         1..80
FT                   /note="MDAIKKKMQMLKLDKENALDRAEQAEADKKAAEDRSKQLEDELVSLQKKLKG
FT                   TEDELDKYSEALKDAQEKLELAEKKATD -> MAGSSSLEAVRRKIRSLQEQADAAEER
FT                   AGSLQRELDQERKLRET (in isoform 4, isoform 5, isoform 7 and
FT                   isoform 8)"
FT                   /evidence="ECO:0000303|PubMed:2022655,
FT                   ECO:0000303|PubMed:2320008"
FT                   /id="VSP_006581"
FT   VAR_SEQ         41..80
FT                   /note="DELVSLQKKLKGTEDELDKYSEALKDAQEKLELAEKKATD -> EDISAKEK
FT                   LLRASEDERDRVLEELHKAEDSLLAADETAAK (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:3838802"
FT                   /id="VSP_006582"
FT   VAR_SEQ         189..212
FT                   /note="KCAELEEELKTVTNNLKSLEAQAE -> QVRQLEEQLRIMDQTLKALMAAED
FT                   (in isoform 8)"
FT                   /evidence="ECO:0000303|PubMed:2022655"
FT                   /id="VSP_006583"
FT   VAR_SEQ         258..284
FT                   /note="DELYAQKLKYKAISEELDHALNDMTSI -> EKVAHAKEENLSMHQMLHQTL
FT                   LELNNM (in isoform 2, isoform 6, isoform 7 and isoform 8)"
FT                   /evidence="ECO:0000303|PubMed:2022655,
FT                   ECO:0000303|PubMed:3838802"
FT                   /id="VSP_006584"
FT   VAR_SEQ         259..284
FT                   /note="ELYAQKLKYKAISEELDHALNDMTSI -> QLYHQLEQNRRLTNELKLALNE
FT                   D (in isoform 3 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:2320008"
FT                   /id="VSP_006585"
FT   VAR_SEQ         259..284
FT                   /note="ELYAQKLKYKAISEELDHALNDMTSI -> KFLCFSPPKTPSSSRMSHLSEL
FT                   CICLLSS (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:2320008"
FT                   /id="VSP_006586"
FT   CONFLICT        52
FT                   /note="G -> A (in Ref. 4; AAA42252)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        279
FT                   /note="N -> K (in Ref. 2; AAA21801 and 3; AAA21805)"
FT                   /evidence="ECO:0000305"
FT   HELIX           2..14
FT                   /evidence="ECO:0007829|PDB:2G9J"
FT   TURN            95..97
FT                   /evidence="ECO:0007829|PDB:2B9C"
FT   HELIX           100..103
FT                   /evidence="ECO:0007829|PDB:2B9C"
FT   TURN            104..107
FT                   /evidence="ECO:0007829|PDB:2B9C"
FT   HELIX           108..123
FT                   /evidence="ECO:0007829|PDB:2B9C"
FT   HELIX           125..208
FT                   /evidence="ECO:0007829|PDB:2B9C"
FT   HELIX           254..282
FT                   /evidence="ECO:0007829|PDB:1KQL"
FT   CONFLICT        P04692-2:260
FT                   /note="V -> G (in Ref. 1; CAA26258)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        P04692-2:275
FT                   /note="H -> D (in Ref. 1; CAA26258)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        P04692-6:275
FT                   /note="H -> D (in Ref. 5; AAA42290)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        P04692-7:239
FT                   /note="H -> D (in Ref. 5; AAA18098)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        P04692-8:239
FT                   /note="H -> D (in Ref. 5; AAA18099)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   284 AA;  32681 MW;  E25609F597A72F4D CRC64;
     MDAIKKKMQM LKLDKENALD RAEQAEADKK AAEDRSKQLE DELVSLQKKL KGTEDELDKY
     SEALKDAQEK LELAEKKATD AEADVASLNR RIQLVEEELD RAQERLATAL QKLEEAEKAA
     DESERGMKVI ESRAQKDEEK MEIQEIQLKE AKHIAEDADR KYEEVARKLV IIESDLERAE
     ERAELSEGKC AELEEELKTV TNNLKSLEAQ AEKYSQKEDK YEEEIKVLSD KLKEAETRAE
     FAERSVTKLE KSIDDLEDEL YAQKLKYKAI SEELDHALND MTSI
//
